Publication date: October 2026 Source: Annals of the Rheumatic Diseases, Volume 85, Issue 10 Author(s): Georgy Gomon, Maxime Raffray, Carlos Betancort Rodríguez, Ádám Misák, Laura Struik, Peta le Roux, Inés Perez-Sancristobal, Sara Curiel Manzanas, Elena Polentinos-Castro, María Isabel Del Cura González, Tamás Kováts, Daniel Prieto-Alhambra, Dennis Mook-Kanamori, Helga Westerlind, Judit Majnik, Gyorgy Nagy, Arthur Pratt, Dieuwke Schiphof, Luis Rodriguez-Rodriguez, Saskia le Cessie
Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care. // Annals of the Rheumatic Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S000349672600289X?dgcid=rss_sd_all
Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care. Annals of the Rheumatic Diseases. https://www.sciencedirect.com/science/article/pii/S000349672600289X?dgcid=rss_sd_all
“Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care.” Annals of the Rheumatic Diseases.
@article{article99703,
title = {Referral pathways and duration of care for musculoskeletal complaints across Europe: an analysis of primary and secondary care},
journal = {Annals of the Rheumatic Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S000349672600289X?dgcid=rss_sd_all}
}
Objective Black patients with systemic sclerosis (scleroderma) have more severe disease than White patients. We investigated whether racial differences in therapeutic responses to mycophenolate mofetil (MMF) could explain this...